Biomarkers 2024

29 February - 01 March 2024 | London, UK

Europe’s flagship event for Biomarker Research returns: engage with the latest trends transforming biomarker & translational research

Presentation Speaker

Explore Biomarkers 2024: Addressing Challenges Across The Biomarkers Discovery & Development Landscape

Join us for the 19th Annual Biomarkers Congress, an immersive experience designed to unveil the forefront of biomarker trends and tools. This event assembles top experts from global pharmaceutical organizations, groundbreaking biotech companies, and esteemed academic institutions, all engaged in diverse therapeutic areas and stages of drug development.

19th Annual Biomarkers Congress

  • Discover the latest integration of biomarkers in drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, NASH and immunology
  • Gain novel insights into key biomarkers for detection, monitoring and diagnosis, including innovative applications of digital markers. Further talks look at early detection of cancer
  • Discuss the use of biomarkers in preclinical and clinical development: trial design & data analysis, assay development, patient stratification & selection and the role of safety & efficacy markers
  • Immerse yourself in over 90 cutting-edge presentations and interactive discussions, participate in 8+ hours of invaluable networking sessions, and explore our exhibition hall featuring 50+ vendor companies.

Agenda at a Glance

  • Day One, Track 1: Biomarkers: Identification & Validation: In Oncology, Immuno- Oncology & Immunology 
  • Day One, Track 2: Biomarkers for Diagnostics & Precision Medicine
  • Day One, Track 3: Biomarkers for Clinical Development
  • Day One, Track 4: Digital Pathology & Imaging and AI For Biomarker Research  
  • Day Two, Track 1: Biomarkers: Identification & Validation: In Neuroscience, NASH & Co-Morbidity
  • Day Two, Track 2: New Emerging Biomarker Technologies
  • Day Two, Track 3: Biomarkers For Clinical Trials & Precision Medicine 
  • Day Two, Track 4: Genomic & Multi- Omic Approaches In Drug Discovery 
NanoString Pre Event Workshop Ad

What to Expect


leading pharma, biotech, & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Biomarkers 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Alexandra Sevko
Director, Translational Research,
Anders Ståhlberg
University of Gothenburg
David Krige
Head of Translational Sciences,
Accession Therapeutics
Gerard Sanderink
Global Head Biomarkers & Clinical Bioanalysis,
Henoch Hong
Associate Director,
Merck Healthcare KGaA
Kimberly Kraynyak
Principal Scientist, Translational Oncology,
Merck Life Science KGaA
Kira Holmstrom
Head of Biomarker Research,
Herantis Pharma
Kon Yew Kwek
Senior Vice President and Clinical Development,
Hummingbird Bioscience
Paul Skipp
Professor of Proteomics,
University of Southampton

All Speakers

Amanda Heslegrave
Senior Research Fellow,
University College London
Andrew Pierce
Vice President, Translational Biology,
Crescendo Biologics
Anna Ettorre
Director of Translational Science, Bioassays and Biomarkers,
AviadoBio Ltd
Anne Remaury
Principal Scientist in Bioanalysis,
Bangwen Xie
Clinical Biomarker Data Operations Manager,
Chris Chamberlain
Head of Precision Medicine Discovery and Development,
Christopher Peters
Clinical Senior Lecturer,
Imperial College London
Debayan Mukherjee
Principal Scientist,
Desiree Schenk
Principal Scientist,
Gritstone Oncology
Dmitri Mikhailov
Donna Finch
Head of Translational and Clinical Science,
Alchemab Therapeutics
Elizabeth Harrington
Executive Director, Translational Medicine,
Emilyanne Leonard
Associate Director,
Emma Leire
Director Translational Biomarkers,
Achilles Tx
Gabriela Kramer-Marek
Group Leader,
The Institute of Cancer Research
Gady Cojocaru
Director of Biomarker Research/ Computational Discovery,
Giovanna Lalli
Director of Scientific Affairs,
UK Dementia Research Institute
Graham Ball
Hans-Dieter Volk
Irene del Molino del Barrio
Principal Scientist,
Jeremy Magnanensi
Project Manager - Biostatistician Biomarkers R&D,
Jose Maria Gonzalez Izarzugaza
Head of Department,
Novo Nordisk
Kathrin Heinzmann
Biomarker scientist,
Cancer Research UK
Kiri Granger
Chief Scientific Officer,
Monument Therapeutics
Kristian Moss Bendtsen
Data Scientist,
Novo Nordisk
Leonor Benhaim
Malgorzata Oczko-Wojciechowska
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch
Maria Udriste
Senior Scientist,
Mohamed Hassanein
Director, Translational Medicine,
Nedjai Belinda
Associate Professor,
Queen Mary University of London
Patrick Fivey
Director of Precision Medicine Policy,
Rita Vicente
Senior Principal Scientist, Head of the Immunology Laboratory,
Rupesh Kanchi Ravi
Senior Director,
Fulgent Pharma
Stephanie Craig
Lecturer in Precision Medicine,
Queen's University Belfast
Steven Piccoli
Head of Clinical Biomarkers,
Steven Piccoli
Head of Clinical Biomarkers,
Thomas Jensen
Chief Executive Officer,
Thomas Hach
Executive Director Patient Engagement, Cardiovascular, Renal & Metabolism Patient Engagement,,
Tim Aitman
Professor of Molecular Pathology and Genetics,
University of Edinburgh

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Unveiling the Essential Criteria for Validating Clinical Biomarkers: A Comprehensive Guide

Biomarkers by Oxford Global will explore the essential criteria for validating clinical biomarkers, shedding light on the steps and challenges involved.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Early Diagnostic Blood Biomarker for Dementia Identified Using Proteomics

The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.

Plan Your Visit

Novotel London West

1 Shortlands,
Hammersmith International Ctre,
London, W6 8DR

Just minutes from three of London's main tube lines (Piccadilly, District and Hammersmith & City) and located in the heart of Hammersmith; Novotel London West is ideally located for trips to Westfield London, Harrods & Kensington High Street. Also conveniently located to Heathrow Airport with excellent road and rail links to the rest of the UK. This large and modern hotel offers on-site parking (chargeable), fitness suite and complimentary Wi-Fi throughout.

By Air

London Heathrow Airport - Novotel London West is accessible from Heathrow via the Underground on the Piccadilly Line – fares cost around £5 into Central London. A taxi from the airport will take approximately 20 minutes and will cost around £30 - £40.

London Gatwick Airport - The Gatwick Express runs every 15 mins - take it to Victoria station, and then get the District line to Hammersmith (about 15 mins). A taxi from the airport will take around 60 mins and cost between £65 - £80.

By Underground & Bus

Hammersmith Underground Station is adjacent to the hotel (3 minutes walk) with access to the Piccadilly, District and Hammersmith & City Lines. When exiting Hammersmith station, turn right and walk across the bus station. Cross over the roads using the island and keep on the right-hand side of Hammersmith Road. Continuing walking for 2 mins, and the hotel is accessible via stone steps.

For buses in central London, take route numbers 9 and 10. The main coach station (London Hammersmith) is 3 minutes walk away.

By Rail

The closest National Rail train station is Kensington Olympia (20 minutes walk).

By Car

Leave the A4 at the Hammersmith turning and proceed along Hammersmith Bridge Road to the large roundabout underneath the flyover. Take the fifth exit off the roundabout. Then turn left into Shortlands - the main hotel entrance and parking will be on your left-hand side.


Novotel London West offers over 240 on-site car parking spaces (charged per hour for residents parking). For further information including a map and full directions, please visit:

Oxford Global have secured a number of bedrooms at Novotel London West at a reduced rate:

Wednesday 28th February 2024 – £190 including VAT and breakfast

Thursday 29th February 2024 – £190 including VAT and breakfast

*Please note: £10 supplement is applicable for double occupancy

Should you wish to book a room, please email The final cut-off date to book bedrooms is Monday 12th February 2024 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to cancellation charges.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biomarkers 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch